PR Blueberries Partnership with Lab.Nutripharma
Blueberries Medical Corp. se asocia con Laboratorios Nutripharma SAS para Transformar los Nutracéuticos y Fitomedicamentos Blueberries...
top of page
4 sept 2023
PR Blueberries Partnership with Lab.Nutripharma
Blueberries Medical Corp. se asocia con Laboratorios Nutripharma SAS para Transformar los Nutracéuticos y Fitomedicamentos Blueberries...
28 jul 2022
Blueberries Medical Announces the launch of new markets for its products,
partnerships in agronomic operation and the Extension of Maturity Date of Convertible Debenture TORONTO, July 29, 2022 (GLOBE NEWSWIRE)...
21 jul 2021
Innovative Cannabis Producer Gets Big Investment from Big-time Investor
Read the article here
30 abr 2021
Blueberries Medical Announces Closing of the Acquisition of BBV Labs – A Milestone in its Argentina
Toronto, Ontario (April 30, 2021) – Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries...
30 abr 2021
Blueberries Medical Reports 2020 Financial Results
Toronto, Ontario (April 30, 2021) – Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries...
26 mar 2021
Blueberries Medical Announces Approval of Nine Psychoactive Strains, Corporate Update
TORONTO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"),...
26 mar 2021
Blueberries Medical Signs Framework Agreement with YVY Life Sciences of Uruguay
Read the article here
20 ene 2021
Blueberries Medical Closes $1M Strategic Financing Led by
a Leading Latin American Private Equity Grroup with Extensive International Cannabis Industry Expertise; Appoints… Toronto, Ontario...
3 dic 2020
Blueberries is pleased to share its operating and financial results for
the three and nine months ended September 30, 2020, as filed on SEDAR: HIGHLIGHTS Earlier this year, Blueberries implemented extensive...
26 oct 2020
26 oct 2020
Blueberries Medical Enters Growing Peruvian Medical Cannabis Market
Read the article here
bottom of page